PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

12 Month Data Release Pres - Q& A, page-13

  1. 16,649 Posts.
    lightbulb Created with Sketch. 4505
    Agreed, contrary to popular opinion there is actually still a significant amount of cash flowing around in the healthcare space. There hasn't really been any sort of slow down in M&A activity which is very promising

    Issue is that every company in the space is looking for a deal now...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.